Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013074
Filing Date
2022-08-10
Accepted
2022-08-10 16:16:45
Documents
46
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20220630x10q.htm   iXBRL 10-Q 1325122
2 EX-31.1 mist-20220630xex31d1.htm EX-31.1 12314
3 EX-31.2 mist-20220630xex31d2.htm EX-31.2 12465
4 EX-32.1 mist-20220630xex32d1.htm EX-32.1 9987
  Complete submission text file 0001558370-22-013074.txt   4739256

Data Files

Seq Description Document Type Size
5 EX-101.SCH mist-20220630.xsd EX-101.SCH 26042
6 EX-101.CAL mist-20220630_cal.xml EX-101.CAL 27237
7 EX-101.DEF mist-20220630_def.xml EX-101.DEF 89146
8 EX-101.LAB mist-20220630_lab.xml EX-101.LAB 247789
9 EX-101.PRE mist-20220630_pre.xml EX-101.PRE 177741
40 EXTRACTED XBRL INSTANCE DOCUMENT mist-20220630x10q_htm.xml XML 936920
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 221152054
SIC: 2834 Pharmaceutical Preparations